Reversible Improvement of Arterial Stenosis and Wall Thickness in Takayasu Arteritis Through Treatment With Tocilizumab
Early diagnosis and initiation of treatment in Takayasu arteritis (TA) is important to prevent irreversible arterial changes. A 39-year-old female was diagnosed with active TA. Subcutaneous administration of tocilizumab (162 mg/week) was initiated in combination with prednisolone (30 mg/d). After 21...
Saved in:
| Main Authors: | Shinichi Nogi, Yusuke Yano, Kako Kodama, Hirotaka Tsuno, Hideki Ogihara, Masahiro Kawakami, Tomoko Ohmori, Shinji Sato, Toshihiro Matsui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2022-11-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A spectacular effect of tocilizumab in Takayasu arteritis
by: Fatma Saïd, et al.
Published: (2024-11-01) -
Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?
by: Congqi Hu, et al.
Published: (2025-06-01) -
Persistent effect of tocilizumab in refractory Takayasu’s arteritis (clinical observation)
by: G. M. Koilubaeva, et al.
Published: (2022-05-01) -
Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
by: Carmen Lasa-Teja, et al.
Published: (2025-01-01) -
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
by: Patrice Cacoub, et al.
Published: (2023-06-01)